Nanomedicine News

RSS

Researchers Develop Nanoparticle Containing Magnetic Resonance Imaging Diagnostic Agent

According to a study of Virginia Commonwealth University and Virginia Tech, a single substance with dual functionality to induce both a diagnostic as well as a therapeutic agent may be helpful in brain tumors to enhance imaging, diagnosis, and treatment procedure.

5 Aug 2011

Nanoparticle Designed to Image and Help Kill Brain Tumors

A single compound with dual function - the ability to deliver a diagnostic and therapeutic agent - may one day be used to enhance the diagnosis, imaging and treatment of brain tumors, according to findings from Virginia ...

4 Aug 2011

Manhattan Scientifics Commercializes Nanotechnology Tools for Treating Cancer

Manhattan Scientifics acquired Senior Scientific in June in order to commercialize innovative nanotechnology tools for detecting, diagnosing, and treating cancer, invented by Dr. Edward R. Flynn.

From Manhattan Scientifics Inc. 4 Aug 2011

Rice University Combines Graphene with Metal Nanowire Grid

Rice University has developed graphene-based electrodes making flexible, transparent electronics possible in reality. The laboratory led by James Tour, Rice University chemist, has formed thin films that enhance LED lighting, solar panels, and touch-screen displays.

3 Aug 2011

Researchers Develop Nanostructure to Aid in Blood Vessels Growth

Researchers at the Northwestern University have created a unique nanostructure that triggers a series of complex actions to promote the formation of new blood vessels, thereby contributing a therapy for situations that require increased flow of blood to supply the needed oxygen to the tissues.

3 Aug 2011

BioAlliance Pharma Starts Clinical Batches Production of its Nanoparticle Transdrug Technology

BioAlliance Pharma, a company developing specialty and orphan oncology products has declared the commencement of the production of clinical batches of Livatag, a regimen to supply doxorubicin in nanoparticle form to chemoresistant cells, for its phase III clinical trial for primary liver cancer.

3 Aug 2011

Nanovircides Plans to Use its Optimization Technology to Enhance its HIVCide Candidate

According to Eugene Seymou, who serves as Chief Executive Officer at NanoViricides, a company developing unique nanomaterials for viral therapy, the company plans to improve its HIVCide candidate using its lead optimization technology.

From NanoViricides, Inc 3 Aug 2011

New Book on Lipid Nanocarriers in Cancer Diagnosis and Therapy

iSmithers Rapra Publishing has announced the release of Lipid Nanocarriers in Cancer Diagnosis and Therapy.

2 Aug 2011

Shasun Pharma Thrust Invests on Nanotech Project for Cancer Treatment

Shasun Pharmaceuticals has planned to make an expansion of its business in two years by investing Rs. 100 crore. A portion of the fund amounting to $6 million will be borrowed from external commercial sources.

2 Aug 2011

IBN Promises Safer Stem Cell Therapy for Cancer Patients

The future of regenerative medicine lies in harnessing the potential of the human body to renew and repair itself. Now, scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have developed a new genetic engineering technique that promises safer stem cell therapy for cancer patients.

From Institute of Bioengineering and Bioimaging 31 Jul 2011